Advent Capital Management TRAVERE THERAPEUTICS INC Transaction History
Advent Capital Management
- $195 Million
- Q2 2025
Number of Shares
20,379,000
Previous 2,640,000
671.93%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions